Amplifying and ameliorating light avoidance in mice with photoreceptor targeting and calcitonin gene‐related peptide sensitization

Documenti analoghi

• Migraine, idiopathic intracranial hypertension, and calcitonin gene‐related peptide antibodies
  di: Irina Krikova, et al.
  Pubblicazione: (2024)
• Genetic migraine disorders and the response to calcitonin gene‐related peptide antagonist treatment
  di: Andrea M. Kuczynski, et al.
  Pubblicazione: (2025)
• Evaluating dual calcitonin gene‐related peptide antagonists for chronic migraine prevention
  di: Kara S. Graves, et al.
  Pubblicazione: (2026)
• Patient reported outcomes and the real‐world use of calcitonin gene–related peptide medications in migraine
  di: Samuel K. Peasah, et al.
  Pubblicazione: (2024)
• Development and pharmacological characterization of novel multi‐ calcitonin gene‐related peptide and pituitary adenylate cyclase‐activating peptide receptor antagonists
  di: Zoe Tasma, et al.
  Pubblicazione: (2025)